7
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Repetitive Measurements of Chlamydia Pneumoniae DNA in Peripheral Blood Mononuclear Cells in Healthy Control Subjects and Dialysis Patients: A Prospective Study

, , , &
Pages 718-723 | Published online: 23 Dec 2012

  • Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990–161–618–25.
  • Smieja M, Mahony J, Petrich A, Boman J, Chernesky M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002; 2: 21.
  • Tegos TJ, Kalodiki E, Sabetai MM, Nicolaides AN. The genesis of atherosclerosis and risk factors: a review. Angiology 2001–52' 89–98.
  • Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–6.
  • Becker AE, de Boer OJ, van der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med 2001; 52: 289–97.
  • Smieja M, Leigh R, Petrich A, Chong S, Kamada D, Hargreave FE, et al. Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis 2002; 2: 12.
  • Muller J, Nyvad O, Larsen NA, Lokkegaard N, Pedersen RS, Solling J, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls. Scand J Clin Lab Invest 2002; 62: 503–9.
  • Tong CY, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313–7.
  • Haranaga S, Yamaguchi H, Leparc GF, Friedman H, Yamamoto Y. Detection of Chlamydia pneumoniae antigenin PBMNCs of healthy blood donors. Transfusion 2001; 41: 114–9.
  • Boman J, Gaydos CA. Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 2000; 181: S452–4.
  • Boman J, Gaydos CA, Quinn TC. Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol 1999; 37: 3791–9.
  • Taylor-Robinson D, Boman J. Comments on the failure to detect Chlamydia pneumoniae in atherosclerosis. Eur J Clin Microbiol Infect Dis 2003; 22: 709–10.
  • Tsirpanlis G, Chatzipanagiotou S, Ioannidis A, Moutafis S, Poulopoulou C, Nicolaou C. Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: correlation with inflammation and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 918–23.
  • Muller J, Moller DS, Kjaer M, Nyvad O, Larsen NA, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis 2003; 35: 704–12.
  • Stenvinkel P, Heimbürger O, Jogerstrand T, Kärnell A, Sa-muelsson A. Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int 1999; 6: 2531–2.
  • Prager M, Turel Z, Speidl WS, Zorn G, Kaun C, Niessner A, et al. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke 2002; 33: 2756–61.
  • Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001; 3: 2748–52.
  • Pitiriga VC, Kotsis VT, Alexandrou MK, Petrocheilou-Paschou VD, Zakopoulou RN, Zakopoulos NA. Essential hypertension is associated with Chlamydia pneumoniae but not Epstein-Barr antibodies. Am J Hypertens 2002; 15: 924–6.
  • Dart AM, Martin JL, Kay S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord 2002; 26: 464–8.
  • Bodetti TJ, Timms P. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas. Infect Immun 2000; 68: 2744–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.